Atossa Therapeutics, Inc.

ATOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
UPLOAD Apr 6, 2018
DEFA14A Apr 2, 2018 DEFA14A
S-1 Mar 27, 2018 S-1
DEF 14A Mar 20, 2018 DEF 14A
PRE 14A Mar 8, 2018 PRE 14A
10-K Mar 8, 2018 10-K
8-K Mar 8, 2018 8-K
8-K Feb 21, 2018 8-K
SC 13G/A Feb 14, 2018
8-K Feb 1, 2018 8-K
SC 13G/A Jan 19, 2018 EMPERY ASSET MANAGEMENT, LP
8-K Dec 22, 2017 8-K
424B5 Dec 21, 2017 424B5
4 Nov 16, 2017 OWNERSHIP DOCUMENT
8-K Nov 14, 2017 8-K
10-Q Nov 13, 2017 10-Q
SC 13G Nov 9, 2017
SC 13G/A Nov 3, 2017 SCHEDULE 13G
SC 13G Nov 3, 2017 SCHEDULE 13G
SC 13G Oct 31, 2017 ATOSSA GENETICS INC.
8-K Oct 30, 2017 FORM 8-K
424B3 Oct 27, 2017 424B3
424B3 Oct 26, 2017 424B3
8-K Oct 25, 2017 8-K
EFFECT Oct 5, 2017
← Newer Page 14 of 26 · 643 filings Older →